Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
 Blood, 15 October 2008, Vol. 112, No. 8, pp. 3425-3433.
Prepublished online as a Blood First Edition Paper on June 10, 2008; DOI 10.1182/blood-2008-02-137372.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Table and Figure
Right arrow All Versions of this Article:
blood-2008-02-137372v1
112/8/3425    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rimsza, L. M.
Right arrow Articles by Gascoyne, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rimsza, L. M.
Right arrow Articles by Gascoyne, R. D.
Related Collections
Right arrow Neoplasia
Right arrowRelated Article in Blood Online
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

NEOPLASIA

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP

Lisa M. Rimsza1, Michael L. LeBlanc2, Joseph M. Unger2, Thomas P. Miller3, Thomas M. Grogan1, Daniel O. Persky3, Ralph R. Martel4, Constantine M. Sabalos4, Bruce Seligmann4, Rita M. Braziel5, Elias Campo6, Andreas Rosenwald7, Joseph M. Connors8, Laurie H. Sehn8, Nathalie Johnson9, and Randy D. Gascoyne9

1 Department of Pathology, University of Arizona, Tucson; 2 Fred Hutchison Cancer Research Center, Seattle, WA; 3 Arizona Cancer Center, Tucson; 4 High Throughput Genomics, Tucson, AZ; 5 Department of Pathology, Oregon Health Sciences Center, Portland; 6 Department of Pathology, University of Barcelona, Barcelona, Spain; 7 Department of Pathology, University of Würzburg, Würzburg, Germany; and Departments of8 Medical Oncology and 9 Pathology, British Columbia Cancer Agency, Vancouver, BC

Gene expression profiling (GEP) on frozen tissues has identified genes predicting outcome in patients with diffuse large B-cell lymphoma (DLBCL). Confirmation of results in current patients is limited by availability of frozen samples and addition of monoclonal antibodies to treatment regimens. We used a quantitative nuclease protection assay (qNPA) to analyze formalin-fixed, paraffin-embedded tissue blocks for 36 previously identified genes (N = 209, 93 chemotherapy; 116 rituximab + chemotherapy). By qNPA, 208 cases were successfully analyzed (99.5%). In addition, 15 of 36 and 11 of 36 genes, representing each functional group previously identified by GEP, were associated with survival (P < .05) in the 2 treatment groups, respectively. In addition, 30 of 36 hazard ratios of death trended in the same direction versus the original studies. Multivariate and variable cut-off point analysis identified low levels of HLA-DRB (< 20%) and high levels of MYC (> 80%) as independent indicators of survival, together distinguishing cases with the worst prognosis. Our results solve a clinical research problem by demonstrating that prognostic genes can be meaningfully quantified using qNPA technology on formalin-fixed, paraffin-embedded tissues; previous GEP findings in DLBCL are relevant with current treatments; and 2 genes, representing immune escape and proliferation, are the common features of the most aggressive DLBCL.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Blocks to paraffin get the CHOP, +R
Richard Byers
Blood 2008 112: 3006-3007. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 haematolHome page
H.-W. Bernd, M. Ziepert, C. Thorns, W. Klapper, H.-H. Wacker, M. Hummel, H. Stein, M.-L. Hansmann, G. Ott, A. Rosenwald, et al.
Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials
Haematologica, November 1, 2009; 94(11): 1569 - 1580.
[Abstract] [Full Text] [PDF]

Home page
 haematolHome page
U. Vitolo, A. Chiappella, E. Angelucci, G. Rossi, A. M. Liberati, M. G. Cabras, B. Botto, G. Ciccone, G. Gaidano, L. Falchi, et al.
Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study
Haematologica, September 1, 2009; 94(9): 1250 - 1258.
[Abstract] [Full Text] [PDF]

Home page
 haematolHome page
L. M. Rimsza, W. C. Chan, R. D. Gascoyne, E. Campo, E. S. Jaffe, L. M. Staudt, J. Delabie, A. Rosenwald, and S. P. Murphy
CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression
Haematologica, April 1, 2009; 94(4): 596 - 598.
[Full Text] [PDF]


click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020